What kind of drug does Mitotane belong to?

Mitotane (Mitotane) is an adrenocortical inhibitor. These drugs reduce the production of adrenocortical hormones by inhibiting or destroying adrenocortical cells. Adrenocortical hormones include glucocorticoids (such as cortisol), mineralocorticoids (such as aldosterone), and sex hormones (such as androgens and estrogens). Mitotane is used to reduce excess levels of these hormones in the body, especially in patients with adrenocortical cancer and Cushing's syndrome.

Mitotane's main mechanism of action is to selectively destroy adrenocortical cells, thereby reducing the synthesis of adrenocortical hormones. It causes cell death by interfering with mitochondrial function in adrenocortical cells. Specifically, Mitotane affects the membrane structure and function of adrenocortical cells and inhibits the synthesis and release of hormones. Its main target is the inner mitochondrial membrane of adrenocortical cells, destroying the integrity and function of these membranes, leading to cell apoptosis.

Mitotane is primarily used to treat adrenocortical carcinoma, a rare but highly aggressive cancer. This drug is also used to treat Cushing's syndrome, especially in people who have not responded to conventional treatments. Mitotane can be used as adjuvant therapy to help control tumor growth and hormone secretion, prolong patient survival, and improve symptoms.

Although mitotane is effective in treating adrenocortical cancer and Cushing's syndrome, it also has significant side effects. Common side effects include gastrointestinal discomfort (such as nausea, vomiting, diarrhea, and loss of appetite), neurological symptoms (such as dizziness, ataxia, and confusion), as well as liver function abnormalities and leukopenia. Due to its impact on adrenocortical function, patients need regular monitoring of blood and liver function indicators during the use of mitotane, and may require supplemental hormone replacement therapy to maintain hormonal balance in the body.

Mitotane is a potent adrenocortical inhibitor used primarily to treat adrenocortical cancer and Cushing's syndrome. Although its side effects are significant, with proper monitoring and management, Mitotane can significantly improve patients' symptoms and quality of life. When using Mitotane, patients should be under the guidance of a doctor and undergo regular examinations to ensure the safety and effectiveness of the treatment.